| An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol … G Darcis, A Kula, S Bouchat, K Fujinaga, F Corazza, A Ait-Ammar, ... PLoS pathogens 11 (7), e1005063, 2015 | 297 | 2015 |
| Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques L Gama, CM Abreu, EN Shirk, SL Price, M Li, GM Laird, KAM Pate, ... Aids 31 (1), 5-14, 2017 | 163 | 2017 |
| Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs A Ait-Ammar, A Kula, G Darcis, R Verdikt, S De Wit, V Gautier, ... Frontiers in microbiology 10, 3060, 2020 | 144 | 2020 |
| Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function A Kula, J Guerra, A Knezevich, D Kleva, MP Myers, A Marcello Retrovirology 8, 1-15, 2011 | 109 | 2011 |
| Fast transcription rates of RNA polymerase II in human cells P Maiuri, A Knezevich, A De Marco, D Mazza, A Kula, JG McNally, ... EMBO reports 12 (12), 1280-1285, 2011 | 108 | 2011 |
| Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1 S Bouchat, N Delacourt, A Kula, G Darcis, B Van Driessche, F Corazza, ... EMBO molecular medicine 8 (2), 117-138, 2016 | 101 | 2016 |
| Transcriptional competence of the integrated HIV‐1 provirus at the nuclear periphery M Dieudonné, P Maiuri, C Biancotto, A Knezevich, A Kula, M Lusic, ... The EMBO Journal 28 (15), 2231-2243, 2009 | 83 | 2009 |
| Replication of severe acute respiratory syndrome coronavirus 2 in human respiratory epithelium A Milewska, A Kula-Pacurar, J Wadas, A Suder, A Szczepanski, ... Journal of virology 94 (15), 10.1128/jvi. 00957-20, 2020 | 65 | 2020 |
| Hyperthermia stimulates HIV-1 replication F Roesch, O Meziane, A Kula, S Nisole, F Porrot, I Anderson, F Mammano, ... PLoS pathogens 8 (7), e1002792, 2012 | 65 | 2012 |
| Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2 F Mangiavacchi, P Botwina, E Menichetti, L Bagnoli, O Rosati, F Marini, ... International journal of molecular sciences 22 (13), 7048, 2021 | 56 | 2021 |
| HIV-1 pre-mRNA commitment to Rev mediated export through PSF and Matrin 3 A Kula, L Gharu, A Marcello Virology 435 (2), 329-340, 2013 | 54 | 2013 |
| Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir G Darcis, S Bouchat, A Kula, B Van Driessche, N Delacourt, C Vanhulle, ... Aids 31 (2), 181-189, 2017 | 42 | 2017 |
| Posttranscriptional regulation of HIV-1 gene expression during replication and reactivation from latency by nuclear matrix protein MATR3 A Sarracino, L Gharu, A Kula, AO Pasternak, V Avettand-Fenoel, ... MBio 9 (6), 10.1128/mbio. 02158-18, 2018 | 30 | 2018 |
| Heterogeneous HIV-1 reactivation patterns of disulfiram and combined disulfiram+ romidepsin treatments A Kula, N Delacourt, S Bouchat, G Darcis, V Avettand-Fenoel, R Verdikt, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (5), 605-613, 2019 | 20 | 2019 |
| Shocking HIV-1 with immunomodulatory latency reversing agents A Kula-Pacurar, A Rodari, G Darcis, C Van Lint Seminars in immunology 51, 101478, 2021 | 17 | 2021 |
| Dynamic post-transcriptional regulation of HIV-1 gene expression A Kula, A Marcello Biology 1 (2), 116-133, 2012 | 15 | 2012 |
| An in-depth comparison of latency-reversing agent combinations in various G Darcis, A Kula, S Bouchat, K Fujinaga, F Corazza, A Ait-Ammar, ... Vitro, 0 | 13 | |
| Chalcogenium-AZT derivatives: A plausible strategy to tackle the RT-inhibitors-related oxidative stress while maintaining their anti-HIV properties JM Sarturi, L Dornelles, NV Segatto, T Collares, FK Seixas, BC Piccoli, ... Current Medicinal Chemistry 30 (21), 2449-2462, 2023 | 10 | 2023 |
| L-arginine improves solubility and ANTI SARS-CoV-2 Mpro activity of Rutin but not the antiviral activity in cells L Sancineto, C Ostacolo, D Ortega-Alarcon, A Jimenez-Alesanco, ... Molecules 26 (19), 6062, 2021 | 8 | 2021 |
| Repression of human T-lymphotropic virus type 1 long terminal repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites S Fauquenoy, G Robette, A Kula, C Vanhulle, S Bouchat, N Delacourt, ... Scientific reports 7 (1), 43221, 2017 | 7 | 2017 |
